throbber
~
`
`\ . National Eye Institute
`
`Ila"./ Research Today ... Vislon Tomorrow
`Treatments for Wet AMD
`(Advanced Neovascular
`AMD)
`
`On this page: Anti-VEGF injections Photody:namic theraP-.Y-
`
`Age-related macular degeneration (AMD) is an eye disease that can blur the center of your
`vision. Wet AMD (also called advanced neovascular AMD) is a serious type of late AMD. It
`happens when a protein called vascular endothelial growth factor (VEGF) makes abnormal
`blood vessels grow in the wrong place in the back of your eye.
`
`The good news is that there are effective treatments for wet AMD.
`
`Learn more aboutAMD
`
`(https://nei.nih.gov/learn-about-eye-health/eye-conditions-and-diseases/age-related(cid:173)
`macular-degeneration)
`There are 2 treatment options that can slow down or stop vision loss from wet AMD:
`
`• Anti-VEGF injections
`
`• Photodynamic therapy (PDT)
`
`If you have vision loss from wet AM D, ask your eye doctor if either of these treatments
`could help you.
`
`Ask your doctor about supplements for AMD
`If you have intermediate AMD in 1 or both eyes, special dietary supplements
`(vitamins and minerals) can help stop it from turning into late AMD.
`
`Learn about supplements for AMP
`(https://nei.nih.gov/learn-about-eye-health/eye-conditions-and-diseases/age-
`https:11www.nei.nih.gov11eam-about-eye-hea1thteye-conditions-and-<1iseases1age-re1ated-macu1ar-<1egeneration1treatments-wet-amd-advanced-neovascu1ar-amd
`
`Novartis Exhibit 2277.001
`Regeneron v. Novartis, IPR2021-00816
`
`

`

`related-macular-degeneration/nutritional-supplements-age-related-macular(cid:173)
`degeneration)
`What are anti-VEGF injections?
`
`The most common treatment doctors use to slow vision loss from wet AMD is called anti(cid:173)
`VEGF injections. These medicines help stop bleeding and leaking from blood vessels in the
`back of your eye. Most people with wet AMD will get anti-VEGF injections as their only
`treatment.
`
`When you get this treatment, your doctor will:
`
`• Put numbing medicine in your eye
`
`• Clean your eye to keep it from getting infected
`
`• Put the anti-VEGF medicine into your eye with a very small needle
`
`Anti-VEGF injections usually only work for a short time, so most people need to get
`them many times. At first, most people need injections once a month. After that, your
`doctor will tell you how often you need injections to help stop vision loss from AMD.
`
`What is photodynamic therapy (PDT)?
`
`Photodynamic therapy (PDT) is a much less common treatment for wet AMD that doctors
`sometimes use along with anti-VEGF injections.
`
`PDT works by using a light-sensitive medicine called verteporfin that "turns on" when hit
`by a specific type of laser (sometimes called a cold laser). Your doctor will shine the laser
`on a very small area in the back of your eye, causing the verteporfin to break down the
`blood vessels that are causing your vision loss.
`
`When you get this treatment, your doctor will:
`
`• Give a shot of verteporfin in your arm
`
`• Put numbing medicine in your eye
`
`• Place a special contact lens on your eye to help guide the laser
`
`• Shine the laser onto the extra blood vessels in the back of your eye
`
`Some people will need to get PDT more than once. Talk to your doctor to find out if
`you will need more treatments to help stop vision loss from AMD.
`
`
`https://www.nei.nih.gov/learn-about-eye-health/eye-conditions-and-diseases/age-related-macular-degeneration/treatments-wet-amd-advanced-neovascular-amd
`
`Novartis Exhibit 2277.002
`Regeneron v. Novartis, IPR2021-00816
`
`

`

`Last updated: June 22, 2021
`
`ContactNEI
`Contact Us(https://nei.nih.gov/contact-us/)
`
`Policies
`Accessibilitv.(https://nei.nih.gov/accessibility-information)
`
`Privaq~(https://nei.nih.gov/nei-website-privacy-policy)
`
`Freedom of Information Act (FOIA)(https://nei.nih.gov/freedom-information-act)
`
`Pisclajmers(https://nei.nih.gov/disclaimers)
`
`Web Policies(https://nei.nih.gov/web-policies)
`
`For NEI Employees
`
`https://www.nei.nih.gov/leam-about-eye-health/eye-conditions-and-diseases/age-related-macular-degeneration/treatments-wet-amd-advanced-neovascular-amd
`
`Novartis Exhibit 2277.003
`Regeneron v. Novartis, IPR2021-00816
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket